178 related articles for article (PubMed ID: 17594934)
21. Cutaneous zygomycosis.
Bonifaz A; Vázquez-González D; Tirado-Sánchez A; Ponce-Olivera RM
Clin Dermatol; 2012; 30(4):413-9. PubMed ID: 22682190
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and treatment of Candida vertebral osteomyelitis: clinical experience with a short course therapy of amphotericin B lipid complex.
Cone LA; Byrd RG; Potts BE; Wuesthoff M
Surg Neurol; 2004 Sep; 62(3):234-7; discussion 237. PubMed ID: 15336867
[TBL] [Abstract][Full Text] [Related]
23. Amphotericin B lipid complex at 3 mg/kg/day for treatment of invasive fungal infections in adults with haematological malignancies.
Martino R; Subirá M; Sureda A; Sierra J
J Antimicrob Chemother; 1999 Oct; 44(4):569-72. PubMed ID: 10588324
[TBL] [Abstract][Full Text] [Related]
24. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS.
Sharkey PK; Graybill JR; Johnson ES; Hausrath SG; Pollard RB; Kolokathis A; Mildvan D; Fan-Havard P; Eng RH; Patterson TF; Pottage JC; Simberkoff MS; Wolf J; Meyer RD; Gupta R; Lee LW; Gordon DS
Clin Infect Dis; 1996 Feb; 22(2):315-21. PubMed ID: 8838189
[TBL] [Abstract][Full Text] [Related]
25. ABELCET treatment.
Boyle JA; Swenson CE
J Clin Pharmacol; 1999 Apr; 39(4):427-8. PubMed ID: 10197303
[No Abstract] [Full Text] [Related]
26. Cure of disseminated zygomycosis with cerebral involvement using high dose liposomal amphotericin B and surgery.
Revankar SG; Hasan MS; Smith JW
Med Mycol; 2007 Mar; 45(2):183-5. PubMed ID: 17365655
[TBL] [Abstract][Full Text] [Related]
27. Use of an amphotericin B lipid complex for treatment of blastomycosis in dogs.
Krawiec DR; McKiernan BC; Twardock AR; Swenson CE; Itkin RJ; Johnson LR; Kurowsky LK; Marks CA
J Am Vet Med Assoc; 1996 Dec; 209(12):2073-5. PubMed ID: 8960189
[TBL] [Abstract][Full Text] [Related]
28. Abdominal wall mucormycosis successfully treated with amphotericin and itraconazole.
Hunter AJ; Bryant RE
J Infect; 2002 Apr; 44(3):203-4. PubMed ID: 12099754
[TBL] [Abstract][Full Text] [Related]
29. Amphotericin B lipid complex in the treatment of invasive fungal infections: results of the Collaborative Exchange of Antifungal Research (CLEAR), an industry-supported patient registry.
Pappas PG
Clin Infect Dis; 2005 May; 40 Suppl 6():S379-83. PubMed ID: 15809923
[No Abstract] [Full Text] [Related]
30. Mortality rates in comparative trials of formulations of amphotericin B.
Frothingham R
Clin Infect Dis; 2001 Aug; 33(4):582-3. PubMed ID: 11462201
[No Abstract] [Full Text] [Related]
31. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
Olson JA; Adler-Moore JP; Schwartz J; Jensen GM; Proffitt RT
Antimicrob Agents Chemother; 2006 Jun; 50(6):2122-31. PubMed ID: 16723574
[TBL] [Abstract][Full Text] [Related]
32. Controlled trials of amphotericin B lipid complex and other lipid-associated formulations.
Winston DJ; Schiller GJ
Clin Infect Dis; 2000 Jan; 30(1):236-7. PubMed ID: 10619780
[No Abstract] [Full Text] [Related]
33. Cutaneous zygomycosis caused by Saksenaea vasiformis following water-related wound in a 24-year-old immunocompetent woman.
Stewardson AJ; Holmes NE; Ellis DH; Howden BP
Mycoses; 2009 Nov; 52(6):547-9. PubMed ID: 19682315
[TBL] [Abstract][Full Text] [Related]
34. Lipid-based antifungal agents.
Arikan S
Cell Mol Biol Lett; 2002; 7(2):220-1. PubMed ID: 12097922
[No Abstract] [Full Text] [Related]
35. Lipid amphotericin B combinations; 'la crème de la crème'?
Hay RJ
J Infect; 1999 Jul; 39(1):16-20. PubMed ID: 10468123
[No Abstract] [Full Text] [Related]
36. Criteria for use of amphotericin B lipid complex injections in adults and children.
Am J Health Syst Pharm; 1996 Nov; 53(22):2751-2. PubMed ID: 9072180
[No Abstract] [Full Text] [Related]
37. Worsening of endogenous Candida albicans endophthalmitis during therapy with intravenous lipid complex amphotericin B.
Virata SR; Kylstra JA; Brown JC; Wohl DA; Cohen MS
Clin Infect Dis; 1999 May; 28(5):1177-8. PubMed ID: 10452666
[No Abstract] [Full Text] [Related]
38. Ileal perforation and reactive hemophagocytic syndrome in a patient with disseminated histoplasmosis: the role of the real-time polymerase chain reaction in the diagnosis and successful treatment with amphotericin B lipid complex.
Guiot HM; Bertrán-Pasarell J; Tormos LM; González-Keelan C; Procop GW; Fradera J; Sánchez-Sergentón C; Méndez W
Diagn Microbiol Infect Dis; 2007 Apr; 57(4):429-33. PubMed ID: 17141457
[TBL] [Abstract][Full Text] [Related]
39. Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain.
Aguado JM; Lumbreras C; González-Vidal D;
Clin Microbiol Infect; 2004 Sep; 10(9):785-90. PubMed ID: 15355408
[TBL] [Abstract][Full Text] [Related]
40. Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.
López-Vélez R; Videla S; Márquez M; Boix V; Jiménez-Mejías ME; Górgolas M; Arribas JR; Salas A; Laguna F; Sust M; Cañavate C; Alvar J;
J Antimicrob Chemother; 2004 Mar; 53(3):540-3. PubMed ID: 14739148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
